Cargando…
Identification of an unfolded protein response-related signature for predicting the prognosis of pancreatic ductal adenocarcinoma
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive lethal malignancy. An effective prognosis prediction model is urgently needed for treatment optimization. METHODS: The differentially expressed unfolded protein response (UPR)‒related genes between pancreatic tumor and normal...
Autores principales: | Fang, Lishan, Chen, Shaojing, Gong, Hui, Xia, Shaohua, Guan, Sainan, Quan, Nali, Li, Yajie, Zeng, Chao, Chen, Ya, Du, Jianhang, Liu, Shuguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885260/ https://www.ncbi.nlm.nih.gov/pubmed/36727081 http://dx.doi.org/10.3389/fonc.2022.1060508 |
Ejemplares similares
-
An endoplasmic reticulum stress-related signature could robustly predict prognosis and closely associate with response to immunotherapy in pancreatic ductal adenocarcinoma
por: Liu, Shuguang, et al.
Publicado: (2023) -
Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
por: Wang, Weijia, et al.
Publicado: (2021) -
The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
por: Lu, Hao, et al.
Publicado: (2022) -
A robust 6-mRNA signature for prognosis prediction of pancreatic ductal adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019) -
Tumor-Infiltrating Immune Cell Signature Predicts the Prognosis and Chemosensitivity of Patients With Pancreatic Ductal Adenocarcinoma
por: Gao, Yuzhen, et al.
Publicado: (2020)